Ultimately, the panel concluded that the current evidence for the MYL3, PDLIM3, PKP2, and PSEN1 genes was not sufficient to support a causative, monogenic relationship with the DCM phenotype. The gene discussed is PKP2; the disease is familial dilated cardiomyopathy.